DISCRIMINATIVE STIMULUS EFFECTS OF PHENCYCLIDINE - PHARMACOLOGICALLY SPECIFIC INTERACTIONS WITH DELTA(9)-TETRAHYDROCANNABINOL AND DELTA(8)-TETRAHYDROCANNABINOL

被引:11
|
作者
DOTY, P
DYKSTRA, LA
PICKER, MJ
机构
[1] UNIV N CAROLINA,DEPT PSYCHOL,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,DEPT PHARMACOL,CHAPEL HILL,NC 27599
关键词
PHENCYCLIDINE; DELTA(9)-TETRAHYDROCANNABINOL; DRUG DISCRIMINATION; DRUG INTERACTIONS; RATS;
D O I
10.1016/0376-8716(94)90122-8
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Rats were trained to discriminate a dose of 1.75 mg/kg phencyclidine (PCP) from saline. During substitution tests, both PCP (0.3-10.0 mg/kg) and the non-competitive NMDA antagonist, MK-801 (0.01-0.3 mg/kg) substituted for the PCP stimulus in a dose-dependent manner. In contrast, Delta(9)-tetrahydrocannabinol (Delta(9)-THC, 0.1-5.6 mg/kg) and Delta(8)-tetrahydrocannabinol (Delta(8)-THC, 0.3-5.6 mg/kg) failed to substitute for the PCP stimulus, up to doses that substantially decreased rate of responding. However, both Delta(9)-THC and Delta(8)-THC partially attenuated the discriminative stimulus effects of the PCP training dose. Furthermore, a dose of 3.0 mg/kg Delta(9)-THC shifted the PCP dose-effect curve for discriminative stimulus effects to the right and shifted the PCP dose-effect curve for rate of responding to the left. The attenuation of the PCP stimulus by Delta(9)-THC lacked a strong dose-dependent relationship and was observed both at doses which did not alter rate of responding, as well as at doses which substantially decreased rate. In contrast to the effects observed with Delta(9)-THC and Delta(8)-THC, morphine, d-amphetamine and chlordiazepoxide failed to attenuate the discriminative stimulus effects of PCP, even at doses that markedly decreased rate of responding. The present findings suggest that Delta(9)-THC and Delta(8)-THC alter the discriminative stimulus effects of PCP in a pharmacologically specific manner.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [1] TOLERANCE TO THE DISCRIMINATIVE STIMULUS EFFECTS OF DELTA(9)-TETRAHYDROCANNABINOL
    WILEY, JL
    BARRETT, RL
    BALSTER, RL
    MARTIN, BR
    BEHAVIOURAL PHARMACOLOGY, 1993, 4 (06): : 581 - 585
  • [2] DISCRIMINATIVE STIMULUS EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL AND DELTA-9-11-TETRAHYDROCANNABINOL IN RATS AND RHESUS-MONKEYS
    WILEY, JL
    BARRETT, RL
    BRITT, DT
    BALSTER, RL
    MARTIN, BR
    NEUROPHARMACOLOGY, 1993, 32 (04) : 359 - 365
  • [3] DISCRIMINATIVE STIMULUS PROPERTIES OF INTRAVENTRICULAR DELTA-9-TETRAHYDROCANNABINOL
    KALLMAN, MJ
    KAEMPF, GL
    HARRIS, LS
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 952 - 952
  • [4] DISCRIMINATIVE STIMULUS PROPERTIES OF INTRACRANIAL ADMINISTRATION OF DELTA-9-TETRAHYDROCANNABINOL
    MOKLER, DJ
    ROSECRANS, JA
    DRUG DEVELOPMENT RESEARCH, 1989, 16 (2-4) : 395 - 405
  • [5] DISCRIMINATIVE STIMULUS PROPERTIES OF DELTA-9-TETRAHYDROCANNABINOL - MECHANISTIC STUDIES
    BROWNE, RG
    WEISSMAN, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9): : S227 - S234
  • [6] CANNABIDIOL ATTENUATES DELTA-9-TETRAHYDROCANNABINOL-LIKE DISCRIMINATIVE STIMULUS EFFECTS OF CANNABINOL
    HILTUNEN, AJ
    JARBE, TUC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 125 (02) : 301 - 304
  • [7] PHARMACOLOGICAL SPECIFICITY OF THE DISCRIMINATIVE STIMULUS EFFECTS OF DELTA(9)-TETRAHYDROCANNABINOL IN RHESUS-MONKEYS
    WILEY, JL
    HUFFMAN, JW
    BALSTER, RL
    MARTIN, BR
    DRUG AND ALCOHOL DEPENDENCE, 1995, 40 (01) : 81 - 86
  • [8] EFFECTS OF DELTA9 TETRAHYDROCANNABINOL ON STIMULUS CONTROL
    LYONS, J
    FERRARO, DP
    LYONS, JE
    SULLIVAN, JG
    DOWNEY, D
    BULLETIN OF THE PSYCHONOMIC SOCIETY, 1973, 2 (5A) : 302 - 304
  • [9] INTERACTIONS BETWEEN DELTA-9-TETRAHYDROCANNABINOL AND PHENCYCLIDINE HYDROCHLORIDE IN RATS
    PRYOR, GT
    HUSAIN, S
    LARSEN, F
    MCKENZIE, CE
    CARR, JD
    BRAUDE, MC
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1977, 6 (01) : 123 - 136
  • [10] DELTA8-TETRAHYDROCANNABINOL AND DELTA9-TETRAHYDROCANNABINOL - EFFECTS ON CULTURED HUMAN LEUCOCYTES
    NEU, RL
    POWERS, HO
    KING, S
    GARDNER, LI
    JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS, 1970, 10 (04): : 228 - &